Over the past few years, Children's Hospital Colorado has significantly enhanced its approach to data utilization. By transitioning from traditional data management methodologies to advanced analytics, the hospital has unlocked new potentials in patient care, operational efficiency, and
Platform engineering is rapidly transforming the healthcare industry, prompting a significant shift in the way healthcare software is developed, managed, and deployed. This approach offers a standardized, self-service platform for developers, which greatly reduces operational overhead, accelerates
The home healthcare sector is rapidly evolving, driven by the increasing desire of aging baby boomers to age in place. This change brings a growing demand for efficient, scalable, and modernized IT solutions. Amedisys, one of the leading home healthcare providers in the U.S., exemplifies this trend
The recent decision by the U.S. Department of Health and Human Services (HHS) to appeal a district court ruling on the use of online tracking technologies in healthcare has sent ripples through the industry. This legal battle pits concerns about patient data privacy against the operational needs of
The health technology (healthtech) investment landscape is experiencing a profound transformation, driven by evolving economic conditions, investor priorities, and the maturation of the industry itself. What was once a sector characterized by a focus on rapid growth and investment in early-stage
Artificial Intelligence (AI) and automation are dramatically reshaping the senior care industry, offering unprecedented levels of personalized care and operational efficiency. These technological advancements are not just easing the workload of caregivers but also enhancing the quality of life for
Ottobock, a nearly century-old health technology company renowned for its focus on B2B sales channels, is now making a significant shift towards a B2C approach. This pivot is led by Martin Wider, Vice-President of Global Marketing, and is driven by the rise of "educated patients" who are
Medicare, the federal health insurance program designed to serve individuals aged 65 and older, faces substantial financial challenges that are growing increasingly severe. Recently, a spotlight has been placed on the potential repercussions of including semaglutide, a high-cost medication
The healthcare industry is on the cusp of a significant transformation driven by artificial intelligence (AI), a catalyst for extensive innovation in patient care, diagnostics, and operational efficiency. In this evolving landscape, Johns Hopkins University, in collaboration with CareFirst
Johnson & Johnson (J&J), one of the leading pharmaceutical companies globally, has announced significant changes to its participation in the 340B drug discount program. Effective October 15, the company will cease providing upfront discounts on two key drugs and move to a rebate system
